| CCA | Canonical correlation analysis |
| CCC | Cell-to-cell communication |
| CCL5 | C-C motif chemokine ligand 5 |
| DCs | Dendritic cells |
| EGA | European Genome–Phenome Archive |
| GEO | Gene Expression Omnibus |
| HSCs | Hematopoietic stem cells |
| ICIs | Immune checkpoint inhibitor therapies |
| IMiDs | Immunomodulatory drugs |
| LR | Ligand–receptor |
| MGUS | Monoclonal gammopathies of uncertain significance |
| MHC | Major Histocompatibility Complex |
| MM | Multiple Myeloma |
| NKs | Natural killer cells |
| PCA | Principal component analysis |
| PD | Programmed death axis |
| pDCs | Plasmacytoid dendritic cells |
| PIs | Proteasome inhibitors |
| PU.1 | Purine-rich box 1 |
| RPMs | Red pulp macrophages |
| RRMM | Relapsed/Refractory Multiple Myeloma |
| scRANK | Single cell rankins analysis tool |
| scRNAseq | Single-cell RNA sequencing |
| SMM | Smouldering Multiple Myeloma |
| TF | Transcription factor |
| TME | Tumour microenvironment |
| UMAP | Uniform manifold approximation and progression |